24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Glaucoma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
07:55
WhatsApp billionaire Jan Koum donates $200 million to Jerusalem hospital Shaare Zedek
18:00
Batsheva Moshe appointed GM Israel market & EMEA tech at Kaltura
16:00
AstraZeneca expands AI partnership with Immunai in deal worth up to $37.5 million
15:20
The strong shekel is becoming Israel’s next economic crisis
More stories
Buzz
Most popular
Daily
Weekly
1
WhatsApp billionaire Jan Koum donates $200 million to Jerusalem hospital Shaare Zedek
2
From defense giants to startups: Israel reconsiders how it buys weapons
3
Kela raising $200 million at $1 billion valuation with backing from Bill Ackman and Eric Schmidt
4
Cisco acquires AI security startup Astrix for $400 million
5
The strong shekel is becoming Israel’s next economic crisis
More news
Glaucoma
4 stories about Glaucoma
The 83-year-old who sold his invention for $466 million, and still walks to work every morning
14.08.25
|
Roni Dori
Michael Belkin’s journey from rooftop experiments to global glaucoma breakthroughs proves some minds never retire.
The Israeli startup treating the silent thief of sight
30.01.22
|
Yafit Ovadia
BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness
Belkin Laser announces $12.2 million raised in series B funding
21.07.20
|
Hagar Ravet
The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years
Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima
21.11.17
|
Lilach Baumer
The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange